QA: Intellia Therapeutics Inc. in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001652130_2021_Intellia_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001652130, Intellia Therapeutics Inc.

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 64,254,000
2 remainder_Liabilities 0
3 AssetsCurrent 616,517,000
4 AssetsNoncurrent 43,862,000
5 PropertyPlantAndEquipmentNet 15,943,000
6 Goodwill 0
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 44,169,000
9 ResearchAndDevelopmentExpense 150,408,000
10 remainder_Expenses 0
11 remainder_Revenues 57,994,000
12 remainder_NetIncome 2,352,000
13 remainder_ComprehensiveNetIncome -260,000
  yvar yval
0 Liabilities 64,254,000
1 Assets 676,322,000
2 Expenses 194,577,000
3 Revenues 57,994,000
4 StockholdersEquity 612,068,000
5 NetIncome -134,231,000
6 ComprehensiveNetIncome -134,361,000
7 BaseVar 497,879,500
8 EconomicCapitalRatio 1.04

Edgar->Model Mapping

Feature Distribution

Change over Time